Corpus Intelligence IC Memo — BANNER HEART HOSPITAL 2026-04-26 04:05 UTC
IC Memo — BANNER HEART HOSPITAL
Investment Committee Memorandum | AZ | 108 beds | Grade C | EBITDA uplift $11.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BANNER HEART HOSPITAL

CCN 030105 | MARICOPA, AZ | 108 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

BANNER HEART HOSPITAL is a 108-bed suburban community hospital in MARICOPA, AZ with $162.2M in net patient revenue and a 17.4% operating margin. The hospital serves a payer mix of 30.9% Medicare, 7.5% Medicaid, and 61.6% commercial.

Thesis: Turnaround. Our ML models identify $11.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 17.4% to 24.8% (+736bps).

Net Revenue HCRIS$162.2M
Current EBITDA COMPUTED$28.3M
Operating Margin COMPUTED17.4%
Occupancy HCRIS49.3%
Revenue / Bed COMPUTED$1.5M
Net-to-Gross HCRIS21.1%
Distress Probability ML47.9%

2. Market Context & Competitive Position

124
AZ Hospitals
-0.8%
State Median Margin
51
Comparable Hospitals

AZ has 124 Medicare-certified hospitals with a median operating margin of -0.8%. The target's margin of 17.4% places it above the state median. Among 51 size-comparable peers (54-216 beds), the median margin is 0.6%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (54-216), prioritizing same-state peers. 51 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BANNER HEART HOSPITAL (Target)AZ108$162.2M17.4%
BANNER GATEWAY MEDICAL CENTERAZ185$573.8M5.2%
MERCY GILBERT MEDICAL CENTERAZ197$381.9M6.3%
KINGMAN REGIONAL MEDICAL CENTEAZ196$373.6M-6.0%
HONORHEALTH DEER VALLEY MED CTAZ204$372.1M3.3%
ABRAZO WEST CAMPUSAZ207$303.3M22.2%
HAVASU REGIONAL MEDICAL CENTERAZ144$256.1M16.9%
SUMMIT HEALTHCAREAZ89$254.1M-2.9%
MOUNTAIN VISTA MEDICAL CENTERAZ162$223.9M-1.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $11.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$3.4M+210bp18mo
Cost to Collect4.5%2.5%$3.2M+200bp12mo
Denial Rate Reduction12.0%6.5%$3.2M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.0M+122bp9mo
Clean Claim Rate88.0%96.0%$104K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$3.4M
Cost to Collect
$3.2M
Denial Rate Reduction
$3.2M
A/R Days Reduction
$2.0M
Clean Claim Rate
$104K
Total EBITDA Uplift$11.9M
Current EBITDA$28.3M
+ RCM Uplift+$11.9M
Pro Forma EBITDA$40.2M
Current Margin17.4%
Pro Forma Margin24.8%
WC Released (1x)$6.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$43.5M$305.9M7.03x47.7%
Base (11x exit)10.0x11.0x$43.5M$350.6M8.06x51.8%
Bull Case9.0x11.0x$39.1M$404.2M10.32x59.5%
Bull (12x exit)9.0x12.0x$39.1M$452.4M11.56x63.1%
Bear Case11.0x10.0x$47.8M$232.1M4.85x37.1%
Bear (11x exit)11.0x11.0x$47.8M$270.8M5.66x41.4%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 51 hospitals with 54-216 beds
  • Same-state prioritization (n=52)
  • Comp margins: P25=-10.0% / P50=0.6% / P75=6.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.